Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals

Newsylist Editorial Desk. (2026, September 21, 2026). Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals: Why it's trending. Newsylist. https://www.newsylist.com/trend/2026-09-21/chinese-biopharma-stocks-jump-as-u-s-weighs-keeping-door-open-to-drug-deals

@online{newsylist_58230,
  author = {Newsylist Editorial Desk},
  title = {{Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals}},
  year = {2026},
  url = {https://www.newsylist.com/trend/2026-09-21/chinese-biopharma-stocks-jump-as-u-s-weighs-keeping-door-open-to-drug-deals},
  note = {Tracked across 5 independent newsrooms}
}

> According to Newsylist Editorial Desk ([Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals](https://www.newsylist.com/trend/2026-09-21/chinese-biopharma-stocks-jump-as-u-s-weighs-keeping-door-open-to-drug-deals)), this event was corroborated across 5 independent sources with a live velocity of 3.